Gibson Neil W
Insider CIK 1555918 · RGLS Chief Scientific Officer · STTK Director · TCRR Director · TIL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TIL Instil Bio, Inc. | A Award deriv | 2026-06-11 | 2026-06-12 | 0 | — | $0 | 6,500 | SEC↗ |
| STTK Shattuck Labs, Inc. | A Award deriv | 2026-05-29 | 2026-06-02 | 81,000 | — | $0 | 81,000 | SEC↗ |
| STTK Shattuck Labs, Inc. | A Award deriv | 2025-07-14 | 2025-07-16 | 33,150 | — | $0 | 33,150 | SEC↗ |
| TIL Instil Bio, Inc. | A Award deriv | 2025-05-28 | 2025-05-29 | 6,500 | — | $0 | 6,500 | SEC↗ |
| STTK Shattuck Labs, Inc. | A Award deriv | 2024-06-21 | 2024-06-21 | 27,700 | — | $0 | 27,700 | SEC↗ |
| TIL Instil Bio, Inc. | A Award deriv | 2024-06-13 | 2024-06-13 | 5,000 | — | $0 | 5,000 | SEC↗ |
| TIL Instil Bio, Inc. | A Award deriv | 2023-06-14 | 2024-01-10 | 1,500 | — | $0 | 1,500 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 12,100 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 16,800 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 8,072 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 12,100 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 5,000 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | D To issuer deriv | 2023-06-01 | 2023-06-01 | 6,270 | — | $0 | 0 | SEC↗ |
| STTK Shattuck Labs, Inc. | A Award deriv | 2023-05-26 | 2023-05-31 | 40,258 | — | $0 | 40,258 | SEC↗ |
| STTK Shattuck Labs, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 40,258 | — | $0 | 40,258 | SEC↗ |
| TIL Instil Bio, Inc. | A Award deriv | 2022-05-20 | 2022-05-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2021-12-09 | 2022-12-19 | 16,800 | — | $0 | 16,800 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2021-12-09 | 2021-12-10 | 12,100 | — | $0 | 12,100 | SEC↗ |
| STTK Shattuck Labs, Inc. | A Award deriv | 2021-06-19 | 2021-06-22 | 3,434 | — | $0 | 3,434 | SEC↗ |
| TIL Instil Bio, Inc. | A Award deriv | 2021-03-18 | 2021-03-22 | 52,000 | — | $0 | 52,000 | SEC↗ |
| STTK Shattuck Labs, Inc. | A Award deriv | 2020-12-22 | 2020-12-28 | 1,286 | — | $0 | 1,286 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2020-12-10 | 2020-12-11 | 12,100 | — | $0 | 12,100 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2020-03-20 | 2020-03-27 | 648 | $7.94 | $5.1K | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2020-03-19 | 2020-03-27 | 3,140 | $7.41 | $23.3K | 648 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2020-03-18 | 2020-03-27 | 3,120 | $6.83 | $21.3K | 3,788 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2020-03-17 | 2020-03-27 | 3,009 | $6.49 | $19.5K | 6,908 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2020-03-16 | 2020-03-27 | 17,723 | $6.60 | $117.0K | 9,917 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | S Sale | 2020-03-13 | 2020-03-27 | 52,000 | $6.52 | $339.0K | 27,640 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2019-12-19 | 2019-12-20 | 5,000 | — | $0 | 5,000 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | J Other | 2019-11-15 | 2020-03-27 | 217,974 | — | $0 | 79,640 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | J Other | 2019-11-13 | 2020-03-27 | 196,177 | — | $0 | 297,614 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | J Other | 2019-11-07 | 2020-03-27 | 212,560 | — | $0 | 493,791 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | A Award deriv | 2019-04-11 | 2019-04-12 | 6,270 | — | $0 | 6,270 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion deriv | 2019-02-19 | 2019-02-21 | 4,375,000 | — | $0 | 0 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | C Conversion | 2019-02-19 | 2019-02-21 | 706,351 | — | $0 | 706,351 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2015-01-28 | 2015-01-30 | 8,655 | $18.66 | $161.5K | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2015-01-28 | 2015-01-30 | 71,345 | $17.98 | $1.28M | 8,655 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2014-12-02 | 2014-12-04 | 90,378 | — | $0 | 90,378 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise deriv | 2014-11-28 | 2014-12-01 | 2,500 | — | $0 | 111,500 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2014-11-28 | 2014-12-01 | 1,500 | $19.63 | $29.4K | 80,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2014-11-28 | 2014-12-01 | 1,000 | $18.80 | $18.8K | 81,500 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise | 2014-11-28 | 2014-12-01 | 2,500 | $1.74 | $4.3K | 82,500 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise deriv | 2014-10-29 | 2014-10-31 | 2,500 | — | $0 | 114,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2014-10-29 | 2014-10-31 | 1,100 | $18.68 | $20.5K | 81,400 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2014-10-29 | 2014-10-31 | 1,200 | $19.67 | $23.6K | 80,200 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2014-10-29 | 2014-10-31 | 200 | $20.41 | $4.1K | 80,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise | 2014-10-29 | 2014-10-31 | 2,500 | $1.74 | $4.3K | 82,500 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise deriv | 2014-10-22 | 2014-10-24 | 3,300 | — | $0 | 116,500 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise | 2014-10-22 | 2014-10-24 | 3,300 | $1.74 | $5.7K | 83,300 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2014-10-22 | 2014-10-24 | 3,300 | $14.44 | $47.7K | 80,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2014-10-20 | 2014-10-22 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise deriv | 2014-09-12 | 2014-09-15 | 2,200 | — | $0 | 119,800 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2014-09-12 | 2014-09-15 | 2,200 | $8.01 | $17.6K | 80,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise | 2014-09-12 | 2014-09-15 | 2,200 | $1.74 | $3.8K | 82,200 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise deriv | 2014-09-11 | 2014-09-15 | 2,000 | — | $0 | 122,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2014-09-11 | 2014-09-15 | 2,000 | $8.01 | $16.0K | 80,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise | 2014-09-11 | 2014-09-15 | 2,000 | $1.74 | $3.5K | 82,000 | SEC↗ |
| """RGLS""" Regulus Therapeutics Inc. | M Exercise deriv | 2014-07-01 | 2014-07-02 | 2,500 | — | $0 | 124,000 | SEC↗ |
| """RGLS""" Regulus Therapeutics Inc. | S Sale | 2014-07-01 | 2014-07-02 | 2,500 | $8.10 | $20.3K | 80,000 | SEC↗ |
| """RGLS""" Regulus Therapeutics Inc. | M Exercise | 2014-07-01 | 2014-07-02 | 2,500 | $1.74 | $4.3K | 82,500 | SEC↗ |
| """RGLS""" Regulus Therapeutics Inc. | M Exercise deriv | 2014-06-17 | 2014-06-18 | 5,000 | — | $0 | 126,500 | SEC↗ |
| """RGLS""" Regulus Therapeutics Inc. | S Sale | 2014-06-17 | 2014-06-18 | 5,000 | $8.05 | $40.3K | 80,000 | SEC↗ |
| """RGLS""" Regulus Therapeutics Inc. | M Exercise | 2014-06-17 | 2014-06-18 | 5,000 | $1.74 | $8.7K | 85,000 | SEC↗ |
| """RGLS""" Regulus Therapeutics Inc. | M Exercise deriv | 2014-04-09 | 2014-04-10 | 2,500 | — | $0 | 42,591 | SEC↗ |
| """RGLS""" Regulus Therapeutics Inc. | M Exercise deriv | 2014-04-09 | 2014-06-18 | 91 | — | $0 | 0 | SEC↗ |
| """RGLS""" Regulus Therapeutics Inc. | M Exercise deriv | 2014-04-09 | 2014-06-18 | 2,409 | — | $0 | 131,500 | SEC↗ |
| """RGLS""" Regulus Therapeutics Inc. | S Sale | 2014-04-09 | 2014-04-10 | 2,500 | $8.11 | $20.3K | 80,000 | SEC↗ |
| """RGLS""" Regulus Therapeutics Inc. | M Exercise | 2014-04-09 | 2014-04-10 | 2,500 | $1.74 | $4.3K | 82,500 | SEC↗ |
| """RGLS""" Regulus Therapeutics Inc. | M Exercise deriv | 2014-03-06 | 2014-06-18 | 2,500 | — | $0 | 91 | SEC↗ |
| """RGLS""" Regulus Therapeutics Inc. | M Exercise deriv | 2014-03-06 | 2014-03-07 | 2,500 | — | $0 | 45,091 | SEC↗ |
| """RGLS""" Regulus Therapeutics Inc. | S Sale | 2014-03-06 | 2014-03-07 | 2,500 | $11.37 | $28.4K | 80,000 | SEC↗ |
| """RGLS""" Regulus Therapeutics Inc. | M Exercise | 2014-03-06 | 2014-03-07 | 2,500 | $1.74 | $4.3K | 82,500 | SEC↗ |
| """RGLS""" Regulus Therapeutics Inc. | M Exercise deriv | 2014-02-06 | 2014-02-07 | 45,000 | — | $0 | 2,591 | SEC↗ |
| """RGLS""" Regulus Therapeutics Inc. | M Exercise | 2014-02-06 | 2014-02-07 | 45,000 | $1.74 | $78.3K | 80,000 | SEC↗ |
| """RGLS""" Regulus Therapeutics Inc. | M Exercise deriv | 2014-02-05 | 2014-02-07 | 2,500 | — | $0 | 47,591 | SEC↗ |
| """RGLS""" Regulus Therapeutics Inc. | S Sale | 2014-02-05 | 2014-02-07 | 17,500 | $8.38 | $146.7K | 35,000 | SEC↗ |
| """RGLS""" Regulus Therapeutics Inc. | M Exercise | 2014-02-05 | 2014-02-07 | 2,500 | $1.74 | $4.3K | 52,500 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise deriv | 2014-01-21 | 2014-01-23 | 4,421 | — | $0 | 701 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2014-01-21 | 2014-01-23 | 4,421 | $8.09 | $35.8K | 50,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise | 2014-01-21 | 2014-01-23 | 4,421 | $2.66 | $11.8K | 54,421 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise deriv | 2014-01-17 | 2014-01-21 | 2,400 | — | $0 | 50,091 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise deriv | 2014-01-17 | 2014-01-21 | 2,079 | — | $0 | 5,122 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2014-01-17 | 2014-01-21 | 4,479 | $8.15 | $36.5K | 50,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise | 2014-01-17 | 2014-01-21 | 2,079 | $2.66 | $5.5K | 54,479 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise | 2014-01-17 | 2014-01-21 | 2,400 | $1.74 | $4.2K | 52,400 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise deriv | 2014-01-16 | 2014-01-17 | 1,100 | — | $0 | 52,491 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise | 2014-01-16 | 2014-01-17 | 1,100 | $1.74 | $1.9K | 51,100 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2014-01-16 | 2014-01-17 | 1,100 | $8.03 | $8.8K | 50,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2013-12-12 | 2013-12-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise deriv | 2013-02-04 | 2013-02-14 | 50,000 | — | $0 | 133,909 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | M Exercise | 2013-02-04 | 2013-02-14 | 50,000 | $1.74 | $87.0K | 50,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2012-12-11 | 2012-12-13 | 112,500 | — | $0 | 112,500 | SEC↗ |